JP3307627B2 - A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii. - Google Patents
A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii.Info
- Publication number
- JP3307627B2 JP3307627B2 JP2000073115A JP2000073115A JP3307627B2 JP 3307627 B2 JP3307627 B2 JP 3307627B2 JP 2000073115 A JP2000073115 A JP 2000073115A JP 2000073115 A JP2000073115 A JP 2000073115A JP 3307627 B2 JP3307627 B2 JP 3307627B2
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- cytochalasin
- sample
- yeast
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Description
【0001】本発明は、自然界に存在利用される耐浸透
圧性酵母(Z.rouxii) より抽出したサイトカラシン様
物質群を製造する方法に関する。The present invention relates to a method for producing a group of cytochalasin- like substances extracted from osmotic pressure-resistant yeast (Z. rouxii) which exists and is used in nature.
【0002】従来、ジゴサッカロマイシス ロキシイは
食品腐敗原因の一つとされており、この酵母の利用法は
まだ発明されていなかった。一方、1960年代英国の
科学者によって初めて発見されたサイトカラシン物質は
可逆性を持ち、抗菌性を始め、動物細胞の分裂を抑制す
る効果等が確認されている。しかし、従来発見れたサイ
トカラシン物質群は全てカビ類だけに存在していた。[0002] Conventionally, the ex-post Saccharomyces Roma Isis Rokishii has been one of the food spoilage cause, usage of this yeast was not been invented yet Tei. On the other hand, the cytochalasin substance first discovered by a British scientist in the 1960's has reversibility, antibacterial properties, and an effect of suppressing the division of animal cells, and the like. However, all the cytochalasin substances discovered so far existed only in molds.
【0003】[0003]
【発明が解決しようとする課題】「カビ類」はその性質
上変性し易く安全で安定した繁殖や取扱いが難しく、生
産設備も高額となるが、「酵母類」は変性し難く安全で
安定した繁殖が可能で生産設備も低額であり、何よりも
“カビの毒性”の有無を心配する必要が無い。サイトカ
ラシンやサイトカラシン様物質は初期に発見されたサイ
トカラシンAやBから現在サイトカラシンWまで発見さ
れてきており、夫々独自の機能を持つ物質として色々な
分野で利用されている(以下これらサイトカラシンA乃
至Wを「サイトカラシン物質」とする)。今までに発見
された上記サイトカラシン物質の一群は新物質を含む可
能性が高く、従来用いられていない微生物を利用して生
産する等の方法が必要である。因みに抗生物や抗菌性物
質の分野でもカビ類から抽出し、既に市場に出回ってい
る薬品に対して強い病害菌等が現れてきており、このた
め新たな方法による新薬品の開発が要求されている。[Problems to be Solved by the Invention] "Moulds" are easily denatured due to their properties, and it is difficult to breed and handle safely and stably, and the production equipment is expensive. However, "Yeasts" are hard to denature and are safe and stable. Reproduction is possible and production equipment is inexpensive, and above all, there is no need to worry about the presence or absence of "mold toxicity". Cytochalasin and cytochalasin-like substances have been discovered from cytochalasin A and B, which were discovered earlier, to cytochalasin W, and are used in various fields as substances with their own functions (hereinafter, these sites). Kalasin Ano
Solstice W is referred to as “cytochalasin substance”) . Discovered ever
A group of the above-mentioned cytochalasin substances has a high possibility of containing a new substance, and requires a method of producing using a microorganism which has not been used conventionally . By the way, in the field of antibiotics and antibacterial substances, fungi have been extracted from molds and strong disease-causing bacteria have emerged against drugs already on the market .
Therefore , development of new chemicals by new methods is required.
【0004】[0004]
【課題を解決するための手段】本発明は上記問題点を解
決することを目的とし、酵母ジゴサッカロマイシスロキ
シイをグルコース等糖の入った培地で培養した後、酢酸
エチル等有機溶媒液で抽出し、その有機溶媒液を完全に
飛ばすことにより得られたサイトカラシン様代謝物群か
ら上記サイトカラシン様物質群を得ることを特徴とする
サイトカラシン様物質群を製造する方法であることを特
徴とする。SUMMARY OF THE INVENTION An object of the present invention is to solve the above-mentioned problems. After culturing yeast digosaccharomysis roxii in a medium containing a sugar such as glucose, the yeast is then dissolved in an organic solvent such as ethyl acetate. wherein the extracted, a method of making a cytochalasin-like substance groups to the organic solvent solution from cytochalasin like metabolites group obtained by completely skipping and obtaining the cytochalasin-like substance groups And
【0005】[0005]
【発明の実施の態様】本発明はジゴサッカロマイシス
ロキシイを糖の入った培地で培養する。培地は普段酵母
を培養する時の培地で、糖はグルコース、スクロース、
マルトース等である。[Aspect of the implementation of the present invention is Jigosakkaromai sheet scan
Roxyi is cultured in a medium containing sugar. The culture medium is a culture medium for culturing yeast usually, and the sugar is glucose, sucrose,
Maltose and the like.
【0006】培地の糖濃度は2%から40%までであ
る。[0006] The sugar concentration of the medium is from 2% to 40%.
【0007】培地のpHは4から7までである。The pH of the medium is between 4 and 7.
【0008】培養温度は10℃から35℃までである。[0008] The culture temperature is from 10 ° C to 35 ° C.
【0009】培養時間は1日から7日までである。[0009] The culturing time is from 1 to 7 days.
【0010】培養後の上澄みの収穫は遠心機にかけるこ
とによるものである。[0010] Harvesting of the supernatant after culturing is by centrifugation.
【0011】代謝物の抽出法は有機溶媒液を利用するこ
とである。The method of extracting metabolites utilizes an organic solvent solution.
【0012】上述の有機溶媒液は酢酸エチル、クロロフ
ォーム等である。The above-mentioned organic solvent liquid is ethyl acetate, chlorofoam or the like.
【0013】その後の操作は溶媒液を完全に飛ばし、得
られた物質をエチルアルコールやクロロフォーム等に溶
かしてジゴサッカロマイシス ロキシイから生産された
代謝物として収穫する。In the subsequent operation, the solvent is completely removed, and the obtained substance is dissolved in ethyl alcohol, chloroform, or the like, and the resulting substance is harvested as a metabolite produced from Digosaccharomysis roxii.
【0014】[0014]
【発明の効果】上述の方法で、ジゴサッカロマイシス
ロキシイを培養することによって回収できる未精製代謝
物群の量は培地1L当たり1.0g〜1.6gである。According to the above method, Digosaccharomysis
The amount of unpurified metabolites that can be recovered by culturing Roxyi is 1.0 g to 1.6 g per liter of medium.
【0015】表1はPaper disc方法を用いて
8属種の細菌に対して抗菌性の検討をした結果を示す表
である。Table 1 is a table showing the results of an investigation of antibacterial activity against bacteria of eight genera using the Paper disc method.
【表1】 [Table 1]
【0016】実験方法はシャレーに普通の寒天培地を入
れ、その上に菌を摂取したソフトアガー(0.5%寒
天)培地をまいた後、その上にZ.rouxiiから抽
出した本発明の物質(以下、サンプルと書く)および対
照物のつけたPaper discを載せて30℃で一
晩培養し、discの周りに現れる透明直径を測った方
法である。サンプルは既にアルコールに溶かしており、
その対照物としては純アルコールを利用した。抗菌性が
あればdiscの周りに菌が繁殖せず、透明になる論理
である。その結果、対照物エタノールでは効果が全くな
かったのに対し、サンプルではサンプルの量を増やせば
増やすほど効果が強くなったことが分かる。An experimental method was as follows. A normal agar medium was placed in a chalet, a soft agar (0.5% agar) medium containing bacteria was inoculated thereon, and Z. This is a method in which a substance of the present invention (hereinafter, referred to as a sample) extracted from R. rouxii and a paper disc to which a control is attached are placed and cultured overnight at 30 ° C., and a transparent diameter appearing around the disc is measured. The sample is already dissolved in alcohol,
Pure alcohol was used as a control. If it has antibacterial properties, it is the logic that bacteria do not propagate around the disc and become transparent. As a result, it was found that the control ethanol had no effect, whereas the effect of the sample became stronger as the amount of the sample was increased.
【0017】図1はBacillus toyoi(バ
チルス、桿菌の一種)に対しての抗菌性を示す図であ
る。実験方法は試験管の中に普通の液体培地を入れサン
プル濃度を1.8mg/ml、3.5mg/mlとなる
ように添加した。サンプルの入っていない(濃度0mg
/ml)ものを対照とした。それぞれに対象菌を摂取し
て30℃で12時間培養し、菌の生育を吸光度計で測っ
た生育曲線である。(a)のグラフは培地のpHを5.
5に調整したもので、(b)のグラフはpHを6.0に
調整したものである。その結果、pH6.0よりpH
5.5で菌の生育がはっきりと抑制されたことが分か
る。pH5.5でサンプルの濃度が3.5mg/mlに
なると菌は全く繁殖しなかったことが分かる。FIG. 1 is a diagram showing the antibacterial activity against Bacillus toyoi (Bacillus, a kind of bacillus). In the experimental method, a normal liquid medium was placed in a test tube, and added so that the sample concentration was 1.8 mg / ml and 3.5 mg / ml. No sample (concentration 0mg
/ Ml) was used as a control. These are growth curves obtained by ingesting the target bacteria and culturing them at 30 ° C. for 12 hours, and measuring the growth of the bacteria with an absorbance meter. The graph in (a) shows the pH of the medium as 5.
5, and the graph in (b) was obtained by adjusting the pH to 6.0. As a result, pH 6.0
It can be seen that the growth of the bacteria was clearly suppressed at 5.5. It can be seen that when the concentration of the sample reached 3.5 mg / ml at pH 5.5, the bacteria did not grow at all.
【0018】図2はEscherichia coli
(大腸菌)に対しての抗菌性を示す図である。実験方法
は図1と同様でpH5.5での結果を表わしている。サ
ンプルの濃度を2.0mg/mlにした場合pHを5.
5に調整したものにも無調整のもの(pH4.6)にも
効果があることが分かる。FIG. 2 shows Escherichia coli.
It is a figure which shows the antibacterial property with respect to (Escherichia coli). The experimental method is the same as in FIG. 1 and shows the results at pH 5.5. When the sample concentration is 2.0 mg / ml, the pH is 5.
It can be seen that there is an effect on both the sample adjusted to 5 and the sample not adjusted (pH 4.6).
【0019】図3はPseudomnas aerug
inosa(緑膿菌)に対しての抗菌性を示す図であ
る。実験方法ならびに結果は図2の大腸菌と同様であ
る。FIG. 3 shows Pseudomonas aerug.
It is a figure which shows the antibacterial property with respect to inosa (Pseudomonas aeruginosa). The experimental method and results are the same as those for E. coli in FIG.
【0020】図4(a),(b)はSalmonell
a enteritidis(食中毒を起すサルモネラ
腸炎菌)に対しての抗菌性を示す図である。実験方法は
図1と同様で、(a)はpH5.5、(b)はpH6.
0での生育グラフである。pH6.0よりpH5.5で
菌の繁殖および生育が共に抑えられたことが分かる。FIGS. 4A and 4B show Salmonell.
It is a figure which shows the antibacterial property with respect to a enteritidis (Salmonella enteritidis which causes food poisoning). The experimental method is the same as in FIG. 1, (a) is pH 5.5, (b) is pH 6.
It is a growth graph at 0. It can be seen that the growth and growth of the bacteria were both suppressed at pH 5.5 to pH 5.5.
【0021】図5はMicrococcus lute
us(球菌の一種)に対してpH5.5での抗菌性を示
す図である。実験方法は図1と同様であるが培養時間を
24時間までした。サンプルの入っていない対照に対
し、サンプル濃度2mg/ml入った試験管には菌が2
4時間経っても繁殖しなかったことが分かる。FIG. 5 shows a Micrococcus lute.
It is a figure which shows the antibacterial property at pH5.5 with respect to us (a kind of cocci). The experimental method was the same as in FIG. 1, but the culture time was up to 24 hours. In the test tube containing the sample concentration of 2 mg / ml, 2 bacteria
It turns out that it did not breed even after 4 hours.
【0022】図6はStaphylococcus a
ureus(ブドウ球菌)に対してpH5.5での抗菌
性を示す図である。実験方法は図1と同様である。サン
プルを2mg/ml入れて無調整pHの4.6のときで
もpHを5.5に調整したときでも菌は24時間まで繁
殖せずサンプルの効果があるということが分かる。FIG. 6 shows Staphylococcus a.
It is a figure which shows the antibacterial property at pH 5.5 with respect to ureus (Staphylococcus). The experimental method is the same as in FIG. It can be seen that the bacteria are not propagated up to 24 hours and the sample is effective, even when the sample is added at 2 mg / ml and the pH is not adjusted to 4.6 or the pH is adjusted to 5.5.
【0023】表2は本発明物質群の各細菌における生育
抑制最低濃度(MIC)を示す表である。Table 2 shows the minimum growth inhibitory concentration (MIC) of each of the substances of the present invention in each of the bacteria.
【表2】 [Table 2]
【0024】この表は図1〜図6に示した抗菌性実験を
各菌に対して行った結果をまとめたものである。細菌は
グラム陽性、グラム陰性と大別してある。各菌に対して
生育抑制最低濃度(MIC)を無調整のpH,pH5.
5、pH6.0にて表わしてある。pHを調整しなけれ
ば少量でサンプルの抗菌性が見られ、このサンプルの効
果はpHを下げると共に現れると言える。無調整のpH
での生育抑制最低濃度(MIC)はサルモネラ菌で0.
7mg/ml,ブドウ球菌で1−2mg/mlである。
大腸菌で2.0mg/mlである。This table summarizes the results of the antibacterial experiments shown in FIGS. Bacteria are roughly classified into Gram-positive and Gram-negative. Unadjusted minimum growth inhibitory concentration (MIC) for each bacteria, pH, pH5.
5, expressed as pH 6.0. If the pH is not adjusted, the antimicrobial properties of the sample can be seen in a small amount, and it can be said that the effect of this sample appears as the pH is lowered. Unadjusted pH
The minimum growth inhibitory concentration (MIC) for Salmonella was 0.1%.
7 mg / ml, 1-2 mg / ml for staphylococci.
2.0 mg / ml for E. coli.
【0025】図7はMicrococcus lute
us(球菌の一種)におけるサンプルの抗菌性が可逆的
であることを示す図である。実験方法は図1と同様であ
る。サンプルの濃度を0.5mg/mlと1mg/ml
にした。対照としてはエタノールを20μl/mlにな
るように加えた。また無添加の普通の培地もContr
olI,ControlIIとして使った。エタノール
を加えた試験管には菌が通常通り生育し、48時間培養
後生育のピークを迎えた。サンプルを0.5mg/ml
加えた試験管には24時間まで菌の生育が抑制されたも
のの24時間後には弱いながら繁殖してきた。それに対
し、サンプルを1.0mg/ml加えた試験管には菌が
168時間経っても育成しなかった。ControlI
とControlIIの試験管では菌の生育は共に通常
であった。それらを12時間培養して菌の数を増やして
からサンプルを0.7mg/mlと1.5mg/mlな
るようそれぞれ入れた。菌の数が増えている培地にサン
プルを0.7mg/ml入れると(ControlI)
生育は数時間抑えられた後通常に上がってきた。一方サ
ンプルを1.5mg/mlまで入れたら(Contro
lII)数の増えた菌も168時間以上まで生育が抑制
された。そのControlII試験管とサンプルを最
初から1.0mg/ml加えた試験管を培養時間168
時間で無菌的に開け、培地を遠心分離して菌細胞を取り
出し、無菌水で2回洗ってから普通の培地に戻して培養
を続けた。その結果、両方共菌が通常通り生育してきた
ことが見られた。結論として下記の点が挙げられる。 (1)本発明の物質群の最適な使用量は菌の数に適して
おり、サンプルの濃度を高めれば増えた数にも対応でき
る。 (2)本発明の物質群はその使用量によって菌の発生を
長時間抑制できる。 (3)本発明の物質群の効果は可逆的で、菌を元の培地
に戻すと通常に生育する。FIG. 7 shows a Micrococcus lute.
FIG. 4 shows that the antibacterial property of a sample in a us (a type of cocci) is reversible. The experimental method is the same as in FIG. Sample concentration of 0.5mg / ml and 1mg / ml
I made it. As a control, ethanol was added to a concentration of 20 μl / ml. In addition, the normal medium without addition is also available from Contr.
olI and ControlII were used. The bacteria grew as usual in the test tube to which ethanol was added, and reached a growth peak after culturing for 48 hours. 0.5 mg / ml sample
Although the growth of the bacteria was suppressed in the added test tube for up to 24 hours, it grew weakly after 24 hours. On the other hand, the test tube to which the sample was added at 1.0 mg / ml did not grow even after passage of the bacteria for 168 hours. ControlI
The growth of the bacteria was normal in the test tubes of Control II and Control II. After culturing them for 12 hours to increase the number of bacteria, samples were added at 0.7 mg / ml and 1.5 mg / ml, respectively. 0.7mg / ml of sample in medium with increasing number of bacteria (Control I)
Growth has been suppressed for a few hours and then increased to normal. On the other hand, when the sample is filled up to 1.5 mg / ml (Contro
1II) The growth of bacteria with an increased number was also suppressed for 168 hours or more. The Control II test tube and the test tube to which the sample was added at 1.0 mg / ml from the beginning were cultured for 168 hours.
The culture medium was centrifuged to remove the bacterial cells, washed twice with sterile water, returned to a normal medium, and the culture was continued. As a result, it was found that both bacteria grew normally. The conclusion is as follows. (1) The optimal use amount of the substance group of the present invention is suitable for the number of bacteria, and can be increased by increasing the concentration of the sample. (2) The substance group of the present invention can suppress the generation of bacteria for a long time depending on the amount of use. (3) The effect of the substance group of the present invention is reversible, and when the bacteria are returned to the original medium, they grow normally.
【0026】図8はMicrococcus lute
us(球菌の一種)の生育に及ぼすサンプルの影響を示
す異層差顕微鏡写真である。 (a)の写真はMicrococcus luteus
菌を通常の培地で12時間培養後に撮ったものである。
菌は通常通り生育し、細胞分裂も通常に起こっているこ
とがわかる。 (b)の写真は培地にサンプルが2.5mg/ml入っ
ていて同じく12時間培養後に撮ったものである。菌の
細胞が膨張している上、分裂も完全にせず二つの細胞が
くっついていることが分かる。FIG. 8 shows a Micrococcus lute.
4 is a heterostratigraphy micrograph showing the effect of a sample on the growth of a us (a type of cocci). The photo of (a) is Micrococcus luteus
The photograph was taken after culturing the bacteria in a normal medium for 12 hours.
It can be seen that the fungus grows normally and cell division occurs normally. The photograph in (b) was taken after the culture was performed for 12 hours with the medium containing 2.5 mg / ml of the sample. It can be seen that the cells of the bacterium are expanding, and the cells are not completely divided, and the two cells are stuck together.
【0027】図9(a)の写真はEscherichi
a coli(大腸菌)、(b)の写真はSalmon
ella enteritidis(サルモネラ腸炎
菌)それぞれの生育に及ぼすサンプルの影響を示す電子
顕微鏡写真である。両方共サンプルを2.5mg/ml
入れた培地に菌を12時間培養後に撮った写真でどちら
にも菌の細胞壁が膨張し一部が突き出ていることが分か
る。FIG. 9A is a photograph of Escherichi.
a coli (E. coli) and (b) are Salmon
11 is an electron micrograph showing the effect of a sample on the growth of each of S. enteritidis (Salmonella enteritidis). 2.5 mg / ml for both samples
Photographs taken after culturing the bacteria in the added medium for 12 hours show that the cell walls of the bacteria expand and partially protrude in both cases.
【0028】応用の具体性を下記に記す。食品分野では 畜産、水産物への“抗菌剤”使用は、O−157
菌、サルモネラ菌の変種害菌化を促す要因となるが「発
明物質」を餌に加えることで、「害菌繁殖を防止し、害
菌の変種」が防げる。農薬使用の軽減可能。 現在約130種類の食品添加剤が認可され食品分野
に用いられるが、その主体である「抗菌性」が「発明
剤」の使用で安全にできる。 第1次産品の食材の保存で、主体となる「雑菌繁殖
防止剤」を用いるが「発明剤」で安全な腐敗防止が可能
となる。化粧品分野では トイレタリー分野の“殺菌剤”は必ずしも人体にと
って無害でないものが含まれるが、安全で肌に相応しい
pHの殺菌効果の「洗浄剤」ができる。 肌に付着させる様々な化粧品の品質保持成分も、必
ずしも安全で刺激性が無いと言えない。「発明剤の添
加」でこの問題が解決できる。医薬品分野では、 AからWまで既に発見、発明された物質は全てカビ
類からつくるもので、非常に高価なもの。酵母からつく
ることで安全で安価な新しい“抗生物質”の生産ができ
る。 細胞の分裂(増殖)を抑止する機能は、ガン細胞、
エイズウイルス、脳細胞などの分裂、増殖を抑止する可
能性を持つ分野。 本発明が病害菌の繁殖を抑止することはデータや写
真にあるように明らかであり、更に「自己免疫機能」に
よる自然治癒療法が期待される分野。The specificity of the application is described below. In the food sector, the use of “antibacterial agents” in livestock and marine products is
It is a factor that promotes the transformation of bacteria and Salmonella into harmful bacteria. By adding the "inventive substance" to the feed, "propagation of harmful bacteria and variation of harmful bacteria" can be prevented. Pesticide use can be reduced. At present, about 130 kinds of food additives are approved and used in the food field, and the "antibacterial property" as the main ingredient can be made safe by using the "inventive agent". In preserving the foodstuffs of the primary product, the main ingredient "antibacterial growth inhibitor" is used, but the "inventive agent" enables safe rot prevention. In the field of cosmetics, "fungicides" in the toiletry field include those that are not necessarily harmless to the human body. The quality-maintaining ingredients of various cosmetics that adhere to the skin are not necessarily safe and non-irritating. This problem can be solved by "adding an inventive agent". In the field of pharmaceuticals, the substances already discovered and invented from A to W are all made from molds and are very expensive. The production of safe and inexpensive new antibiotics can be made by using yeast. The function of inhibiting cell division (proliferation) is
Fields that have the potential to inhibit the division and proliferation of AIDS virus, brain cells, etc. It is clear from the data and photographs that the present invention inhibits the propagation of disease-causing bacteria, and is a field where natural healing therapy by "autoimmune function" is expected.
【0029】サイトカラシン様物質群(全く同じ群か良
く似た性状の新物質群か定かでない)は全てカビ類から
抽出していた。医療分野でも既にこれまで様々な可能性
を持っている。しかし、本発明は「酵母起源」で初めて
の物質として抗菌性、細胞分裂抑止機能とその可逆性を
立証して、広い範囲の「食品」に先ず応用できることが
特徴であり、化粧品、医薬品へと付加価値の高い分野へ
利用できる。The cytochalasin-like substance group (exactly the same substance group or a new substance group with similar properties is not known) was all extracted from molds. The medical field already has various possibilities. However, the present invention is characterized by its ability to be applied to a wide range of foods, demonstrating its antibacterial properties, cell division inhibitory function and its reversibility as the first substance of "yeast origin" and its application to cosmetics and pharmaceuticals. It can be used for high value-added fields.
【図1】Bacillus toyoi(バチルス、桿
菌の一種)に対しての抗菌性を示す図である。FIG. 1 is a diagram showing antibacterial activity against Bacillus toyoi (Bacillus, a kind of bacillus).
【図2】Escherichia coli(大腸菌)
に対しての抗菌性を示す図である。FIG. 2 Escherichia coli (E. coli)
It is a figure which shows the antibacterial property with respect to.
【図3】Pseudomnas aeruginosa
(緑膿菌)に対しての抗菌性を示す図である。FIG. 3. Pseudomonas aeruginosa
It is a figure which shows the antibacterial property with respect to (Pseudomonas aeruginosa).
【図4】(a)、(b)はSalmonella en
teritidis(食中毒を起すサルモネラ腸炎菌)
に対しての抗菌性を示す図である。FIG. 4 (a) and (b) are Salmonella en
teritidis (Salmonella enteritidis causing food poisoning)
It is a figure which shows the antibacterial property with respect to.
【図5】Micrococcus luteus(球菌
の一種)に対してpH5.5での抗菌性を示す図であ
る。FIG. 5 is a diagram showing the antibacterial activity of Micrococcus luteus (a type of cocci) at pH 5.5.
【図6】Staphylococcus aureus
(ブドウ球菌)に対してpH5.5での抗菌性を示す図
である。FIG. 6: Staphylococcus aureus
It is a figure which shows the antibacterial property at pH 5.5 with respect to (Staphylococcus).
【図7】Micrococcus luteus(球菌
の一種)におけるサンプルの抗菌性が可逆的であること
を示す図である。FIG. 7 is a diagram showing that the antibacterial property of a sample in Micrococcus luteus (a kind of cocci) is reversible.
【図8】発明物質(酵母ジゴサッカロマイシス ロキシ
イよりの抽出物質)の球菌(IFO 12708〈Mi
crococcus luteus〉)に及ぼす影響を
示す異層差顕微鏡写真で、(a)は通常の培地で12時
間培養後、(b)は発明物質2.5mg/mlの入った
培地で12時間培養後に撮ったものである。FIG. 8 shows a coccus (IFO 12708 <Mi) of an inventive substance (extracted substance from yeast Digosaccharomysis roxii).
crococcus luteus>), in which (a) was taken after culturing for 12 hours in a normal medium, and (b) for 12 hours after culturing in a medium containing 2.5 mg / ml of the inventive substance. It is a thing.
【図9】(a)は発明物質(酵母ジゴサッカロマイシス
ロキシイよりの抽出物質)2.5mg/mlの入った
培地で12時間培養後に撮影した大腸菌(IFO 33
01〈Escherichia coli〉)の電子顕
微鏡写真、(b)は発明物質(酵母ジゴサッカロマイシ
ス ロキシイよりの抽出物質)2.5mg/mlの入っ
た培地で12時間培養後に撮影したサルモネラ腸炎菌
(IFO 3313〈Salmonella ente
ritidis〉)の電子顕微鏡写真である。FIG. 9 (a) shows Escherichia coli (IFO 33) photographed after culturing for 12 hours in a medium containing 2.5 mg / ml of an inventive substance (extract from yeast Digosaccharomysis roxii).
01 <Escherichia coli>, and (b) shows Salmonella enteritidis (IFO) photographed after culturing for 12 hours in a medium containing 2.5 mg / ml of an inventive substance (extract from yeast Digosaccharomysis roxii). 3313 <Salmonella ente
litidis>).
フロントページの続き (72)発明者 橋永 文男 鹿児島県鹿児島市郡元1丁目21番24号 鹿児島大学農学部内 (56)参考文献 特開 昭54−86696(JP,A) 日本食品科学工学会第46回大会要旨集 (1999)p.50,2Ea5 (58)調査した分野(Int.Cl.7,DB名) C12P 17/18 BIOSIS(DIALOG) WPI(DIALOG)Continuation of the front page (72) Inventor Fumio Hashinaga 1-21-24 Gunori, Kagoshima City, Kagoshima Prefecture Kagoshima University Faculty of Agriculture (56) References JP-A-54-86696 (JP, A) Japan Society for Food Science and Technology 46th Meeting Abstracts (1999) p. 50, 2Ea5 (58) Field surveyed (Int. Cl. 7 , DB name) C12P 17/18 BIOSIS (DIALOG) WPI (DIALOG)
Claims (1)
であって、酵母ジゴサッカロマイシス ロキシイをグル
コース等糖の入った培地で培養した後、培地から分離し
た培養液より酢酸エチル等の有機溶媒液で抽出し、かつ
当該有機溶媒液を完全に飛ばすことにより未精製のサイ
トカラシン様代謝物群を得ることを特徴とする酵母ジゴ
サッカロマイシス ロキシイからサイトカラシン様物質
群を製造する方法。1. A method for producing a group of cytochalasin- like substances, comprising culturing yeast Digosaccharomysis roxii in a medium containing a sugar such as glucose, and then extracting an organic solvent such as ethyl acetate from a culture solution separated from the medium. Extracting a crude cytochalasin-like metabolite group by extracting it with a liquid and completely removing the organic solvent liquid from the yeast. Digosaccharomysis roxii .
How to make a group .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000073115A JP3307627B2 (en) | 2000-02-09 | 2000-02-09 | A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000073115A JP3307627B2 (en) | 2000-02-09 | 2000-02-09 | A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii. |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001218594A JP2001218594A (en) | 2001-08-14 |
JP3307627B2 true JP3307627B2 (en) | 2002-07-24 |
Family
ID=18591415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000073115A Expired - Fee Related JP3307627B2 (en) | 2000-02-09 | 2000-02-09 | A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii. |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3307627B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1889966A (en) * | 2003-10-13 | 2007-01-03 | 雀巢技术公司 | Moderating the effect of endotoxins |
DE602004021831D1 (en) | 2003-10-13 | 2009-08-13 | Nestec Sa | Modification of the action of endotoxins |
-
2000
- 2000-02-09 JP JP2000073115A patent/JP3307627B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
日本食品科学工学会第46回大会要旨集(1999)p.50,2Ea5 |
Also Published As
Publication number | Publication date |
---|---|
JP2001218594A (en) | 2001-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Furneri et al. | In vitro antimycoplasmal activity of oleuropein | |
Lauzon et al. | Enzymatic capabilities of bacteria associated with apple maggot flies: a postulated role in attraction | |
US5840318A (en) | Methods and compositions for modulating immune systems of animals | |
Zhao et al. | Contributions of tropodithietic acid and biofilm formation to the probiotic activity of Phaeobacter inhibens | |
Hanlon et al. | Essential microbiology for pharmacy and pharmaceutical science | |
US20240138418A1 (en) | Methods and compositions for control of arthropod pests | |
Ng et al. | Antimycotic activity of Xenorhabdus bovienii (Enterobacteriaceae) metabolites against Phytophthora infestans on potato plants | |
Liaqat et al. | Biofilm formation, maturation and prevention: a review | |
JP3307627B2 (en) | A method for producing a group of cytochalasin-like substances from the yeast Zygosaccharomycesrouxii. | |
Khani et al. | Postbiotics as candidates in biofilm inhibition in food industries | |
Kumar et al. | Assessment of the antimicrobial efficacy of hydroalcoholic fruit extract of cranberry against Socransky complexes and predominant cariogenic, mycotic and endodontic climax communities of the oral cavity: An extensive in-vitro study | |
Hauck et al. | Histomonas meleagridis (Protozoa: Trichomonadidae): analysis of growth requirements in vitro | |
Stewart et al. | Influence of temperature on gaffkemia, a bacterial disease of the lobster Homarus americanus | |
Fiorentini et al. | Influence of bacteriocins produced by Lactobacillus plantarum BN in the shelf-life of refrigerated bovine meat | |
Twitty et al. | Motor inhibition in Amblystoma produced by Triturus transplants | |
CN106561716A (en) | Agricultural antibacterial complex enzyme preparation and preparation method thereof | |
JP3649787B2 (en) | Prophylactic agent for enterococcal infection in fish and use thereof | |
Bretz et al. | Resistance to actinomycin D of Escherichia coli after frozen storage | |
JP2006526573A (en) | Red pigment with an algicidal effect derived from Hahera Chejuensis | |
JP7393805B2 (en) | Antibacterial composition and method for producing the same | |
Cooper et al. | A bacterial disease of the Darwin's frog (Rhinoderma darwini) | |
JPH09140373A (en) | New fungal strain belonging to exserohilum monoceras and its use | |
Sousa et al. | ‘Alecrim Pimenta’nanoformulated essential oil (Lippia sidoides) as additive in consortium silages | |
RU2241346C2 (en) | Method for preserving fodder using bacterial preparation | |
JP2001072522A (en) | Starch preparation for fungus of genus fusarium and preservation of fungus of genus fusarium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080517 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090517 Year of fee payment: 7 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090517 Year of fee payment: 7 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |